These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11374718)

  • 21. [Substantiation of enterosane application for the treatment of celiac disease].
    Bogdarin IuA; Repin AA
    Eksp Klin Gastroenterol; 2004; (4):36-8. PubMed ID: 15568666
    [No Abstract]   [Full Text] [Related]  

  • 22. Pancreatic enzyme replacement therapy for young cystic fibrosis patients.
    Munck A; Duhamel JF; Lamireau T; Le Luyer B; Le Tallec C; Bellon G; Roussey M; Foucaud P; Giniès JL; Houzel A; Marguet C; Guillot M; David V; Kapel N; Dyard F; Henniges F
    J Cyst Fibros; 2009 Jan; 8(1):14-8. PubMed ID: 18718819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In brief: pancreatic enzyme products.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):12. PubMed ID: 21304445
    [No Abstract]   [Full Text] [Related]  

  • 24. Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis.
    Kalnins D; Corey M; Ellis L; Durie PR; Pencharz PB
    J Pediatr; 2005 Apr; 146(4):489-93. PubMed ID: 15812451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of enzyme substitution on steatorrhea caused by maldigestion].
    Ewers HR
    MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1715-6. PubMed ID: 105250
    [No Abstract]   [Full Text] [Related]  

  • 26. Medical nutrition therapy for cystic fibrosis: beyond pancreatic enzyme replacement therapy.
    Hayek KM
    J Am Diet Assoc; 2006 Aug; 106(8):1186-8. PubMed ID: 16863713
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA approves third pancrelipase product: Unapproved products illegal to market after April 28.
    Traynor K
    Am J Health Syst Pharm; 2010 May; 67(10):776. PubMed ID: 20479094
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro evaluation of the gastrointestinal delivery of acid-sensitive pancrelipase in a next generation enteric capsule using an exocrine pancreatic insufficiency disease model.
    Jannin V; Duysburgh C; Gonzalez V; Govaert M; Agisson M; Marzorati M; Madit N
    Int J Pharm; 2023 Jan; 630():122441. PubMed ID: 36442722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymatic therapy in patients with chronic pancreatitis.
    Greenberger NJ
    Gastroenterol Clin North Am; 1999 Sep; 28(3):687-93. PubMed ID: 10503144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ins and outs of oral pancreatic enzymes.
    Meyer JH
    N Engl J Med; 1977 Jun; 296(23):1347-8. PubMed ID: 859534
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea].
    Kölbel C; Layer P; Hotz J; Goebell H
    Med Klin (Munich); 1986 Feb; 81(3):85-6. PubMed ID: 3641037
    [No Abstract]   [Full Text] [Related]  

  • 32. Administration of Pancrelipase as Effective Treatment for Hepatic Steatosis After Pancreatectomy.
    Kishi Y; Shimada K; Nara S; Esaki M; Kosuge T
    Pancreas; 2015 Aug; 44(6):983-7. PubMed ID: 25899648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubility of oral pancreatic enzyme supplement capsules in biological fluids.
    Robb TS; Davidson GP; Cooper DM
    Lancet; 1980 Sep; 2(8193):544. PubMed ID: 6105599
    [No Abstract]   [Full Text] [Related]  

  • 34. Pertzye approved for pancreatic insufficiency.
    Traynor K
    Am J Health Syst Pharm; 2012 Jul; 69(13):1094. PubMed ID: 22722581
    [No Abstract]   [Full Text] [Related]  

  • 35. Pancrelipase for treatment-refractory diarrhea associated with nelfinavir.
    Ryan A
    Am J Health Syst Pharm; 2000 Jun; 57(12):1177-8. PubMed ID: 10911520
    [No Abstract]   [Full Text] [Related]  

  • 36. So you have a clogged feeding tube, now what?
    Seiveright M
    Perspectives; 2003; 27(2):3-4. PubMed ID: 14619707
    [No Abstract]   [Full Text] [Related]  

  • 37. [Dietetic studies on malnutrition and steatorrhea caused by pancreatic insufficiency].
    Fraga C; Leite CA
    Prensa Med Argent; 1971 Dec; 58(4):2101-6. PubMed ID: 5140328
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of medium chain triglycerides (MCT) in gastroenterology].
    Demole MJ
    Presse Med (1893); 1971 Sep; 79(40):1735-7. PubMed ID: 5120818
    [No Abstract]   [Full Text] [Related]  

  • 39. Digestive Enzyme Replacement Therapy: Pancreatic Enzymes and Lactase.
    Felicilda-Reynaldo RF; Kenneally M
    Medsurg Nurs; 2016; 25(3):182-5. PubMed ID: 27522847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study.
    Colombo C; Fredella C; Russo MC; Faelli N; Motta V; Valmarana L; Longo L; D'Orazio C
    Pancreas; 2009 Aug; 38(6):693-9. PubMed ID: 19531972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.